Here you find financial information to facilitate the assessment of ChromoGenics as placement.

Investor Relations task is to continuously provide the capital market with information about ChromoGenics operation and financial development.
Please contact us if you have questions or comments.

Follow link to read more.


IR contact

Susanne Andersson
+46 730 66 8904


Interim Report Jan-Mar 2018
Apr 27, 2018 

Annual General Meeting 2018
May 16, 2018 

Interim Report Jan-Jun 2018
Jul 20, 2018 

Interim Report Jan-Sep 2018
Oct 26, 2018 

Follow us: